|
CN111004800A
|
|
CRISPR/Cas9 system targeting HPV subtype 16/18 oncogene E6/E7
|
|
CN110499313A
|
|
Inhibit the siRNA molecule and its application of MITF
|
|
CN108929870A
|
|
Inhibit the siRNA molecule and its application of HBV
|
|
CN106420792A
|
|
Micro-nucleic acid acne-removing compound
|
|
CN106086012A
|
|
A kind of external preparation method of linear double-strand adeno-associated virus genome
|
|
CN106119269A
|
|
A kind of method preparing linear ssdna in escherichia coli
|
|
CN107281103A
|
|
Liposomal formulation and its application with high content positive lipid compound
|
|
US2016053267A1
|
|
Multi-targets interfering RNA molecules and their applications
|
|
CN104152398A
|
|
Method for separating prostate tissues and establishing primary epithelial cells and/or interstitial cells
|
|
CN104877028A
|
|
Anti-DOTA chimeric antigen receptor-modified T cells and anti-tumor applications thereof
|
|
WO2014134797A1
|
|
Lipidosome preparation, preparation method and application thereof
|
|
CN103993002A
|
|
New production process for large-scale synthesis of long-chain RNA drugs
|
|
CN102866052A
|
|
Cell staining kit and use method thereof
|
|
CN102895190A
|
|
Liposome preparation and preparation method and application thereof
|
|
CN102793639A
|
|
Plant extract-mediated drug transdermal introducing system and transdermal method thereof
|
|
CN103131756A
|
|
Small RNA detection method and use thereof
|
|
WO2012040118A1
|
|
The application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
|
|
CN102727436A
|
|
Nucleic acid liposome drug preparation
|
|
CN102727513A
|
|
Small RNAs targeting tissue factor (TF) gene and use thereof
|
|
CN102719434A
|
|
Specific modification for inhibiting RNA interference off-target effect
|
